Robert Wiggins
Neurology · Charlotte, NCNPI 1386006872
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $97,073 of the $138,251 with a category attached, or 70.2%. 7 manufacturers reported payments, led by MDD US Operations, LLC at 44.5% of the total. 2025 is the largest year on record at $84,745, more than ten times the $111 reported in 2022. Among neurology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 258 payments — averaging $535.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$62K
- AbbVie$57K
- Acadia Pharmaceuticals Inc$19K
- Supernus Pharmaceuticals, Inc.$181
- Medtronic$144
- Biogen$122
- plus $111 from 1 others
Across 11 payments — averaging $5590.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$61K
What the payments were for
- Consulting fees$19,58014%
- Speaking & faculty fees$97,07370%
- Travel & lodging$16,95412%
- Food & beverage$4,6263%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MDD US Operations, LLC | 133 | $61,515 |
| AbbVie | 92 | $56,957 |
| Acadia Pharmaceuticals Inc | 27 | $19,221 |
| Supernus Pharmaceuticals, Inc. | 3 | $181 |
| Medtronic | 1 | $144 |
| Biogen | 1 | $122 |
| Boston Scientific | 1 | $111 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GOCOVRI$58,994
- VYALEV$53,919
- NUPLAZID$18,463
- Duopa$243
- PERCEPT PC BRAINSENSE$144
- GENERAL DBS$111
How this compares
$138,251 in reported general payments places this provider in the 95th percentile of 566 neurology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 25 | $197,432 |
| RytaryCarbidopa/Levodopa | 138 | $137,071 |
| NuplazidPimavanserin Tartrate | 16 | $87,613 |
| GocovriAmantadine Hcl | 21 | $75,919 |
| BotoxOnabotulinumtoxina | 34 | $67,035 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 830 | $22,415 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 247 | $14,284 |
| Tetrabenazine | 18 | $5,234 |
| AmantadineAmantadine Hcl | 81 | $5,030 |
| Gabapentin | 230 | $4,905 |
| Rasagiline Mesylate | 27 | $4,122 |
| Primidone | 169 | $3,747 |
| Entacapone | 16 | $3,034 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 51 | $2,115 |
| Donepezil Hcl | 141 | $1,686 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $19,221 | $87,61316 claims |
| MDD US Operations, LLCGocovri | $61,515 | $75,91921 claims |
| AbbVieBotox | $56,957 | $67,03534 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 566 neurology providers in North Carolina.
Other neurology in Charlotte
- Jill ConwayCharlotte$1M
- Matthew CarraroCharlotte$695K
- Megan DonnellyCharlotte$601K
- Sanjay IyerCharlotte$581K
- Urvi DesaiCharlotte$262K
- Danielle Englert DoggettCharlotte$215K
- Ardith CourtneyCharlotte$120K
- Joseph ChipmanCharlotte$118K
- Kurt WashburnCharlotte$66K
- Ziad HageCharlotte$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.